The key finding was that estrogen receptor (ER) expression, a hallmark of luminal-type breast cancer, typically diminishes after passaging of organoids, concurrent with a phenotypic shift from luminal to basal-like characteristics. This evidence concerns the gene ESR1 and breast cancer.